While inactivation of APC in FAP and sporadic CRCs is due to APC mutation, an often-unnoticed fact is that, in other cancers, APC inactivation often results from the hypermethylation of APC’s promoter, and its epigenetic silencing. This evidence concerns the gene APC and cancer.